Immune Cell Infiltration and Causal Relationships with Prostate Cancer: A Transcriptomic and Mendelian Randomization Study
By: Haishu Xu, Sifeng Zhou, Yunlong Chen, Aijun Shi, Weiwei Ge, Liyu Zhang and Yan Wang
Authors
Haishu Xu
Department of Pharmacy, Rudong Hospital of Traditional Chinese Medicine, Nantong, China
School of Clinical Medicine, Medical College of Yangzhou University, Yangzhou, China
Sifeng Zhou
Department of Endocrinology, Rudong Hospital of Traditional Chinese Medicine, Nantong, China
School of Clinical Medicine, Medical College of Yangzhou University, Yangzhou, China
Jiangsu Key Laboratory of Experimental & Translational Non-coding RNA Research, Yangzhou, China
Yunlong Chen
Department of Oncology, Rudong Hospital of Traditional Chinese Medicine, Nantong, China
School of Clinical Medicine, Medical College of Yangzhou University, Yangzhou, China
Aijun Shi
Department of Clinical Laboratory, Rudong Hospital of Traditional Chinese Medicine, Nantong, China
School of Clinical Medicine, Medical College of Yangzhou University, Yangzhou, China
Weiwei Ge
Department of Pathology, Rudong Hospital of Traditional Chinese Medicine, Nantong, China
School of Clinical Medicine, Medical College of Yangzhou University, Yangzhou, China
Liyu Zhang
Department of Endocrinology, Rudong Hospital of Traditional Chinese Medicine, Nantong, China
School of Clinical Medicine, Medical College of Yangzhou University, Yangzhou, China
Yan Wang
Department of Endocrinology, Rudong Hospital of Traditional Chinese Medicine, Nantong, China
School of Clinical Medicine, Medical College of Yangzhou University, Yangzhou, China
Language: English
Submitted on: Dec 12, 2024
Accepted on: Jun 26, 2025
Published on: Sep 17, 2025
Published by: Helenic Society of Medical Oncology
In partnership with: Paradigm Publishing Services
Related subjects:
© 2025 Haishu Xu, Sifeng Zhou, Yunlong Chen, Aijun Shi, Weiwei Ge, Liyu Zhang, Yan Wang, published by Helenic Society of Medical Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.